Skip to main content
SpringerLink
Log in

Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson’s disease

  • Review
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

Deep brain stimulation (DBS) is an effective technique for treating Parkinson’s disease (PD) in the middle and advanced stages. The subthalamic nucleus (STN) is the most common target for clinical treatment using DBS. While STN-DBS can significantly improve motor symptoms in PD patients, adverse cognitive effects have also been reported. The specific effects of STN-DBS on cognitive function and the related mechanisms remain unclear. Thus, it is imperative to identify the influence of STN-DBS on cognition and investigate the potential mechanisms to provide a clearer view of the various cognitive sequelae in PD patients. For this review, a literature search was performed using the following inclusion criteria: (1) at least 10 patients followed for a mean of at least 6 months after surgery since the year 2006; (2) pre- and postoperative cognitive data using at least one standardized neuropsychological scale; and (3) adequate reporting of study results using means and standard deviations. Of ∼170 clinical studies identified, 25 cohort studies (including 15 self-controlled studies, nine intergroup controlled studies, and one multi-center, randomized control experiment) and one metaanalysis were eligible for inclusion. The results suggest that the precise mechanism of the changes in cognitive function after STN-DBS remains obscure, but STN-DBS certainly has effects on cognition. In particular, a progressive decrease in verbal fluency after STN-DBS is consistently reported and although executive function is unchanged in the intermediate stage postoperatively, it tends to decline in the early and later stages. However, these changes do not affect the improvements in quality of life. STN-DBS seems to be safe with respect to cognitive effects in carefully-selected patients during a follow-up period from 6 months to 9 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al.Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006, 21(Suppl 14): S290–304.

    Article  PubMed  Google Scholar 

  2. Sun B, Chen S, Zhan S, Le W, Krahl SE. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl 2007, 97: 207–214.

    Article  CAS  PubMed  Google Scholar 

  3. Phillips L, Litcofsky KA, Pelster M, Gelfand M, Ullman MT, Charles PD. Subthalamic nucleus deep brain stimulation impacts language in early Parkinson’s disease. PLoS One 2012, 7: e42829.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Troster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurol 2006, 5: 578–588.

    Article  PubMed  Google Scholar 

  5. Castelli L, Perozzo P, Zibetti M, Crivelli B, Morabito U, Lanotte M, et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol 2006, 55: 136–144.

    Article  CAS  PubMed  Google Scholar 

  6. De Gaspari D, Siri C, Di Gioia M, Antonini A, Isella V, Pizzolato A, et al. Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson’s disease. Parkinsonism Relat Disord 2006, 12: 289–295.

    Article  PubMed  Google Scholar 

  7. Erola T, Heikkinen ER, Haapaniemi T, Tuominen J, Juolasmaa A, Myllyla VV. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson’s disease. Acta Neurochir (Wien) 2006, 148: 389–394.

    Article  CAS  Google Scholar 

  8. Aybek S, Gronchi-Perrin A, Berney A, Chiuve SC, Villemure JG, Burkhard PR, et al. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson’s disease. Mov Disord 2007, 22: 974–981.

    Article  PubMed  Google Scholar 

  9. Castelli L, Lanotte M, Zibetti M, Caglio M, Rizzi L, Ducati A, et al. Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study. J Neurol 2007, 254: 1238–1243.

    Article  CAS  PubMed  Google Scholar 

  10. Ory-Magne F, Brefel-Courbon C, Simonetta-Moreau M, Fabre N, Lotterie JA, Chaynes P, et al. Does ageing influence deep brain stimulation outcomes in Parkinson’s disease? Mov Disord 2007, 22: 1457–1463.

    Article  PubMed  Google Scholar 

  11. Rothlind JC, Cockshott RW, Starr PA, Marks WJ Jr. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson’s disease. J Int Neuropsychol Soc 2007, 13: 68–79.

    Article  PubMed  Google Scholar 

  12. Contarino MF, Daniele A, Sibilia AH, Romito LM, Bentivoglio AR, Gainotti G, et al. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 2007, 78: 248–252.

    Article  CAS  PubMed  Google Scholar 

  13. Klempirova O, Jech R, Urgosik D, Klempir J, Spackova N, Roth J, et al. Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson’s disease. Prague Med Rep 2007, 108: 315–323.

    CAS  PubMed  Google Scholar 

  14. Heo JH, Lee KM, Paek SH, Kim MJ, Lee JY, Kim JY, et al. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease. J Neurol Sci 2008, 273: 19–24.

    Article  PubMed  Google Scholar 

  15. Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, et al. Motor and cognitive outcome in patients with Parkinson’s disease 8 years after subthalamic implants. Brain 2010, 133: 2664–2676.

    Article  PubMed  Google Scholar 

  16. Kishore A, Rao R, Krishnan S, Panikar D, Sarma G, Sivasanakaran MP, et al. Long-term stability of effects of subthalamic stimulation in Parkinson’s disease: Indian Experience. Mov Disord 2010, 25: 2438–2444.

    Article  PubMed  Google Scholar 

  17. Merola A, Zibetti M, Angrisano S, Rizzi L, Ricchi V, Artusi CA, et al. Parkinson’s disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 2011, 134: 2074–2084.

    Article  PubMed  Google Scholar 

  18. Zibetti M, Merola A, Rizzi L, Ricchi V, Angrisano S, Azzaro C, et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease. Mov Disord 2011, 26: 2327–2334.

    Article  PubMed  Google Scholar 

  19. Yamanaka T, Ishii F, Umemura A, Miyata M, Horiba M, Oka Y, et al. Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson’s disease. Clin Neurol Neurosurg 2012, 114: 347–351.

    Article  PubMed  Google Scholar 

  20. Smeding HM, Speelman JD, Koning-Haanstra M, Schuurman PR, Nijssen P, van Laar T, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 2006, 66: 1830–1836.

    Article  CAS  PubMed  Google Scholar 

  21. York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease. J Neurol Neurosurg Psychiatry 2008, 79: 789–795.

    Article  CAS  PubMed  Google Scholar 

  22. Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Kirsch-Darrow L, et al. Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using reliable change. Clin Neuropsychol 2009, 23: 385–405.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Zangaglia R, Pacchetti C, Pasotti C, Mancini F, Servello D, Sinforiani E, et al. Deep brain stimulation and cognitive functions in Parkinson’s disease: A three-year controlled study. Mov Disord 2009, 24: 1621–1628.

    Article  PubMed  Google Scholar 

  24. Castelli L, Rizzi L, Zibetti M, Angrisano S, Lanotte M, Lopiano L. Neuropsychological changes 1-year after subthalamic DBS in PD patients: A prospective controlled study. Parkinsonism Relat Disord 2010, 16: 115–118.

    Article  PubMed  Google Scholar 

  25. Alegre M, Hallett M, Olanow CW, Obeso JA. Technical advances in deep brain stimulation: how far is enough? Mov Disord 2012, 27: 341–342.

    Article  PubMed  Google Scholar 

  26. Smeding HM, Speelman JD, Huizenga HM, Schuurman PR, Schmand B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson’s Disease. J Neurol Neurosurg Psychiatry 2011, 82: 754–760.

    Article  PubMed  Google Scholar 

  27. Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord 2011, 17: 321–327.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Zangaglia R, Pasotti C, Mancini F, Servello D, Sinforiani E, Pacchetti C. Deep brain stimulation and cognition in Parkinson’s disease: an eight-year follow-up study. Mov Disord 2012, 27: 1192–1194.

    Article  PubMed  Google Scholar 

  29. Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008, 7: 605–614.

    Article  PubMed  Google Scholar 

  30. Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2004, 75: 834–839.

    Article  CAS  PubMed  Google Scholar 

  31. Wang XP, Sun BM, Ding HL. Changes of procedural learning in Chinese patients with non-demented Parkinson disease. Neurosci Lett 2009, 449: 161–163.

    Article  CAS  PubMed  Google Scholar 

  32. Balaz M, Rektor I, Pulkrabek J. Participation of the subthalamic nucleus in executive functions: An intracerebral recording study. Mov Disord 2008, 23: 553–557.

    Article  PubMed  Google Scholar 

  33. Jiang Y, Shen X, Wang X, Li W. Procedural learning changes in patients with Wilson’s disease. Neur Regen Res 2011, 6 (18): 1410–1414.

    Google Scholar 

  34. Kalbe E, Voges J, Weber T, Haarer M, Baudrexel S, Klein JC, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009, 72: 42–49.

    Article  CAS  PubMed  Google Scholar 

  35. Volkmann J, Daniels C, Witt K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 2010, 6: 487–498.

    CAS  PubMed  Google Scholar 

  36. Naskar S, Sood SK, Goyal V, Dhara M. Mechanism(s) of deep brain stimulation and insights into cognitive outcomes in Parkinson’s disease. Brain Res Rev 2010, 65: 1–13.

    Article  PubMed  Google Scholar 

  37. Wang XP, Ding HL. Alzheimer’s disease: epidemiology, genetics, and beyond. Neurosci Bull 2008, 24: 105–109.

    Article  PubMed  Google Scholar 

  38. Lefaucheur R, Derrey S, Martinaud O, Wallon D, Chastan N, Gerardin E, et al. Early verbal fluency decline after STN implantation: is it a cognitive microlesion effect? J Neurol Sci 2012, 321: 96–99.

    Article  PubMed  Google Scholar 

  39. Wojtecki L, Timmermann L, Jorgens S, Sudmeyer M, Maarouf M, Treuer H, et al. Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol 2006, 63: 1273–1276.

    Article  PubMed  Google Scholar 

  40. Hanna-Pladdy B, Heilman KM. Dopaminergic modulation of the planning phase of skill acquisition in Parkinson’s disease. Neurocase 2010, 16: 182–190.

    Article  PubMed  Google Scholar 

  41. Romito LM, Albanese A. Dopaminergic therapy and subthalamic stimulation in Parkinson’s disease: a review of 5-year reports. J Neurol 2010, 257: S298–304.

    Article  PubMed  Google Scholar 

  42. Saint-Cyr JA, Trepanier LL. Neuropsychologic assessment of patients for movement disorder surgery. Mov Disord 2000, 15: 771–783.

    Article  CAS  PubMed  Google Scholar 

  43. Xia R, Mao ZH. Progression of motor symptoms in Parkinson’s disease. Neurosci Bull 2012, 28: 39–48.

    Article  PubMed  Google Scholar 

  44. Liang J, Hu X, Zhou X, Jiang X, Cao Y, Wang L, et al. Fiveyear follow-up of 23 asymmetrical Parkinson’s disease patients treated with unilateral subthalamic nucleus stimulation. Neural Regen Res 2012, 7(1): 1428–1435.

    Google Scholar 

  45. Zhang KZ, Wan Q, Zhang L, Yuan YS. Valuation of therapeutic effects and safety of bilateral stimulation of the subthalamic nucleus in improving dyskinesia on “Off” time of Parkinson’s disease. Chin J Clin Neurosci 2012, 20(3): 290–294. [Article in Chinese]

    Google Scholar 

  46. Frankemolle AM, Wu J, Noecker AM, Voelcker-Rehage C, Ho JC, Vitek JL, et al. Reversing cognitive-motor impairments in Parkinson’s disease patients using a computational modelling approach to deep brain stimulation programming. Brain 2010, 133: 746–761.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Shanghai First People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200080, China

    Bin Wu, Lu Han & Xiao-Ping Wang

  2. Department of Functional Neurosurgery, Ruijin Hospital Affiliated to the School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China

    Bo-Min Sun

  3. Department of Neurosurgery, Changhai Hospital, Second Military University, Shanghai, 200433, China

    Xiao-Wu Hu

Authors
  1. Bin Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lu Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bo-Min Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiao-Wu Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiao-Ping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiao-Ping Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, B., Han, L., Sun, BM. et al. Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson’s disease. Neurosci. Bull. 30, 153–161 (2014). https://doi.org/10.1007/s12264-013-1389-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-013-1389-9

Keywords

Search

Navigation